logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
S

Stergios A. Pοlyzos

school of medicine

63H-index
522Paper Count
1.7WCitation Count
Published Papers 262
Publication Date
logo
Acromegaly and Metabolic Dysfunction–Associated Steatotic Liver Disease: Clinical and Therapeutic Implications
errCurrent Obesity Reports
IF11
err2026-08-05
err0
errOAAI
errStergios A. Polyzos; Alessandro Mantovani; Giovanni Targher
errShare
errSave
Exploring the relationship between microplastic exposure and bone health
errEndocrine Connections
IF2.8
err2026-05-01
err0
PREAI
errGogakos, Apostolos, I; Polyzos, Stergios A.; Anastasilakis, Dimitrios A.; Anastasilakis, Athanasios D.
errShare
errSave
Helicobacter pylori Infection as a Potential Risk Factor for Barrett's Esophagus
errJournal of Gastroenterology and Hepatology
IF3.4
err2026-04-08
err0
PREAI
errJannis Kountouras; Stergios A. Polyzos; Evangelos Kazakos; Michael Doulberis; Apostolis Papaefthymiou; Maria Tzitiridou-Chatzopoulou; Christos Liatsos; Elisabeth Vardaka; Ioannis S. Papanikolaou
errShare
errSave
Levothyroxine for metabolic dysfunction-associated steatohepatitis: it is the prime time for randomized controlled trials
errEndocrine Practice
IF4.6
err2026-03-30
err0
PREAI
errStergios A. Polyzos; Paul M. Yen; Leonidas H. Duntas
errShare
errSave
Adult Growth Hormone Deficiency and Metabolic Dysfunction-Associated Steatotic Liver Disease
errCurrent Obesity Reports
IF11
err2026-02-19
err0
errOAAI
errStergios A. Polyzos; Alessandro Mantovani; Giovanni Targher
errShare
errSave
Helicobacter pylori infection with metabolic-associated fatty liver disease and Colorectal Neoplasms
errDigestive and Liver Disease
IF3.8
err2026-01-22
err0
errOAAI
errJannis Kountouras; Nikolaos Kapetanakis; Stergios A. Polyzos; Evangelos Kazakos; Christos Zavos; Elisabeth Vardaka
errShare
errSave
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis?
errdiabetes, obesity and metabolism
IF0
err2026-01-20
err0
PREAI
errStergios A. Polyzos MD; Jannis Kountouras MD; Leonidas H. Duntas MD; Giovanni Targher MD
errShare
errSave
Helicobacter pylori and Porphyromonas gingivalis as risk factors in the enteric metaplasia-dysplasia-oncogenesis sequence
errARAB JOURNAL OF GASTROENTEROLOGY
IF1.1
err2025-11-01
err0
PREAI
errKountouras, Jannis; Zavos, Christos; Polyzos, Stergios A.; Tzitiridou-Chatzopoulou, Maria; Polyzou-Laspia, Paraskevi; Chatzopoulos, Dimitrios; Doulberis, Michael; Vardaka, Elisabeth; Papanikolaou, Ioannis S.
errShare
errSave
Repurposing levothyroxine for managing metabolic dysfunction-associated steatotic liver disease
errEndocrine
IF2.9
err2025-10-23
err0
errOAAI
errLeonidas H. Duntas; Stergios A. Polyzos; Ulrike Gottwald-Hostalek; Bogumila Urgatz; Paul M. Yen
errShare
errSave
AdipoRon exerts divergent effects on hepatic and bone metabolism
errDiabetes, Obesity and Metabolism
IF0
err2025-10-06
err0
PREAI
errStergios A. Polyzos MD; Jannis Kountouras MD
errShare
errSave
Non-invasive indices of hepatic steatosis and fibrosis for the prediction of obstructive coronary artery disease
errJournal of Clinical Lipidology
IF4.6
err2025-09-19
err0
errOAAI
errDimitrios Trygoniaris; Nikolaos Mittas; Andreas S. Papazoglou; Efstratios Karagiannidis; Fani Chatzopoulou; Stergios A. Polyzos; Dimitrios Chatzidimitriou; Lefteris Angelis; Ioannis S. Vizirianakis
errShare
errSave
COUP-TFII as a potential therapeutic target for metabolic dysfunction-associated steatotic liver disease
errMEDICAL HYPOTHESES
IF0.8
err2025-09-01
err0
PREAI
errPolyzos, Stergios A.; Makri, Evangelia S.; Pettas, Spyros; Xanthopoulos, Konstantinos; Goulas, Antonis; Topouzis, Stavros
errShare
errSave
The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review
errCurrent Obesity Reports
IF11
err2025-08-12
err0
errOAAI
errIlias D. Vachliotis; Stergios A. Polyzos
errShare
errSave
The effects of anti-obesity medications on bone metabolism: A critical appraisal
errdiabetes obesity metabolism
IF0
err2025-06-24
err0
PREAI
errAthanasios D. Anastasilakis MD, PhD; Julien Paccou MD; Andrea Palermo MD; Stergios A. Polyzos MD
errShare
errSave
Circulating Fibroblast Growth Factor-21 in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
errCurrent Obesity Reports
IF11
err2025-06-04
err0
errOAAI
errIoanna Filimidou; Myrsini Orfanidou; Antonis Goulas; Olga Giouleme; Stergios Α. Polyzos
errShare
errSave
Unraveling the pathogenetic overlap of Helicobacter pylori and metabolic syndrome-related Porphyromonas gingivalis: Gingipains at the crossroads and as common denominator
errMicrobiological Research
IF6.9
err2025-05-31
err0
PREAI
errMichael Doulberis; Dimitrios Tsilimpotis; Stergios A. Polyzos; Elisabeth Vardaka; Aryan Salahi-Niri; Abbas Yadegar; Jannis Kountouras
errShare
errSave
Long-Term Denosumab Treatment in Adults with Juvenile Paget Disease
errCALCIFIED TISSUE INTERNATIONAL
IF3.2
err2025-04-13
err0
errOAAI
errPolyzos, Stergios A.; Anastasilakis, Konstantinos; Cundy, Tim; Kita, Marina
errShare
errSave
The impact of sensitization patterns on COPD severity and exacerbations: Insights from a case-control and longitudinal study
errEuropean Journal of Internal Medicine
IF6.1
err2025-04-12
err0
PREAI
errMeropi Karakioulaki; Caroline Maria Berkemeier; Leticia Grize; Ingmar Heijnen; Stergios A. Polyzos; Antonis Goulas; Michael Tamm; Daiana Stolz
errShare
errSave
Metabolic dysfunction-associated steatotic liver disease and malignancies: Unmasking a silent saboteur
errMETABOLISM-CLINICAL AND EXPERIMENTAL
IF11.9
err2025-04-01
err0
PREAI
errPolyzos, Stergios A.; Mantzoros, Christos S.
errShare
errSave
Follistatins, activins and inhibins during osteoporosis therapy with denosumab or zoledronate and after their discontinuation
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-01-23
err0
PREAI
errAnastasilakis, Athanasios D.; Makras, Polyzois; Polyzos, Stergios A.; Kumar, Ajay; Kalra, Bhanu; Mantzoros, Christos S.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
C
Christos S. Mantzoros
H-index: 142 · Papers: 960
G
Giovanni Targher
H-index: 124 · Papers: 836
H
Herbert Tilg
H-index: 116 · Papers: 811
E
Elisabetta Bugianesi
H-index: 113 · Papers: 673
E
Evangelos Terpos
H-index: 106 · Papers: 1.6K
View more